Resultados: 22

    Classification et traitement des cas de pneumonie chez l’enfant dans les établissements de santé selon l’OMS: version révisée: résumé des données

    Dans le but d’accroître le nombre d’enfants ayant accès au traitement adapté, la classification et le guide thérapeutique simplifiés de l’OMS pour la prise en charge de la pneumonie de l’enfant dans les établissements de santé de premier niveau et les services de consultation ambulatoire o...

    Meningitis outbreak response in sub-Saharan Africa: WHO guideline

    For over 100 years, major epidemics of meningococcal disease have occurred every few years within the African meningitis belt, which runs across the continent from Senegal to Ethiopia. The objectives of this review were to revise WHO guidelines on control of epidemic meningitis in subSaharan Africa conce...

    The use of delamanid in the treatment of multidrug-resistant tuberculosis: interim policy guidance

    The aim of this guidance is to provide the interim principles that should guide the use of delamanid in conjunction with WHO-recommended MDR-TB treatment. It also specifies the essential treatment and management conditions for use of this drug, in particular the patient's eligibility criteria and safety ...

    Guidance for national tuberculosis programmes on the management of tuberculosis in children

    This Guideline outlines the purpose and the target audience of the second edition of Guidance for national tuberculosis programmes on the management of tuberculosis in children. It discusses the difference between TB in children and adolescents and TB in adults and provides an estimate of the burden of c...

    Guidelines on the treatment of skin and oral HIV-associated conditions in children and adults

    Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest daily management problems faced by health care workers caring for patients with HIV infection. As the CD4 count declines below 200 cells/mm3, the prev...

    Hormonal contraceptive methods for women at high risk of HIV and living with HIV: 2014 guidance statement

    During 9–12 March 2014, WHO convened a meeting of the Guideline Development Group (GDG) comprising 52 individuals representing a wide range of stakeholders, for the purpose of reviewing, and where appropriate, revising its Medical eligibility criteria for contraceptive use, fourth edition (MEC) guidanc...

    Personal protective equipment in the context of filovirus disease outbreak response

    This document provides a summary of recommendations for personal protective equipment (PPE) to be used by health workers providing clinical care for patients with filovirus infection (Ebola and Marburg). The document covers the principles guiding the PPE use, recommendations, PPE technical specifications...

    Revised WHO classification and treatment of pneumonia in children at health facilities: evidence summaries

    The revised guidelines present two major changes to existing guidelines: (A) there are now just 2 categories of pneumonia instead of 3 (“pneumonia” which is treated at home with oral amoxicillin and “severe pneumonia” which requires injectable antibiotics) and (B) oral amoxicillin replaces oral c...

    WHO guidelines for treatment of cervical intraepithelial neoplasia 2-3 and adenocarcinoma in situ: cryotherapy, large loop excision of the transformation zone, and cold knife conization

    Cervical intraepithelial neoplasia (CIN) is a premalignant lesion that is diagnosed by histology as CIN1, CIN2, or CIN3. If left untreated, CIN2 or CIN3 (collectively referred to as CIN2+) can progress to cervical cancer. There are three principal treatments for CIN available in low- and middle-income co...

    WHO position paper on mammography screening

    Every year, breast cancer kills more than 500,000 women around the world. In resource-poor settings, a majority of women with breast cancer are diagnosed at an advanced stage of disease; their five-year survival rates are low, ranging from 10-40%. In settings where early detection and basic treatment are...